170.53 USD
▼+4.64-0.20%
2026-08-03
市值
$10.05B
市盈率
—
EPS
-3.25
股息率
—
52 周区间
73.16 – 184.00
成交量
799.72K
Beta
0.75
目标价
193.62
52W 低 73.1652W 高 184.00
价格走势
公司简介
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and ...